1. AAPS Advances in the Pharmaceutical Sciences Series;Wang,2015
2. Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia;Bross;Clin Cancer Res,2001
3. Antibody–drug conjugates: an emerging concept in cancer therapy;Chari;Angew Chem Int Ed,2014
4. Preliminary single agent activity of IMGN853, a folate receptor alpha (FRa)-targeting antibody–drug conjugate (ADC), in platinum-resistant epithelial ovarian cancer (EOC) patients (pts): Phase I trial;Moore,2015
5. Antibodies As Carriers of Cytotoxicity;Sedlacek,1992